Comparative Study of Antioxidant Activities of the Leaves and Stem of Ipomoea aquatica Forsk (Water Spinach)

Leaves and stem extracts of Ipomoea aquatic Forsk were analysed for their antioxidant activities. Folin-Ciocalteu and AlCl3 methods were used to quantify total phenolic and flavonoid contents while 1,1-diphenyl-2-picryl hydrazyl (DPPH) radical assay was used to examine the antioxidant activity of the extracts. The respective total phenolic and flavonoid contents of the stem (18.00 ±  1.20 and 20.00 ± 1.40 μg Catechin equivalent, CEQ g-1 DW) show no significant (p > 0.05) difference when compared to leaves (16.00 ± 1.10 and 30.00 ± 2.1 μg CEQ g-1 DW). In DPPH scavenging assay, the reference standard i.e. vitamin C (IC50 = 0.0660μg/ml) had significantly (p<0.05) higher scavenging activity than the stem (IC50 = 35.96μg/ml) which in turn is significantly higher (p<0.05) than the leaves (IC50 = 176.92μg/ml). From the results it can be concluded that stem and leaves of Ipomoea aquatica had similar antioxidants activity.Keywords: Ipomoea aquatica, antioxidant, DPPH Assay, Scavenging activity, phenolic, flavonoi

Evaluation of Nutrient and Anti-nutrient Contents of Parkia biglobosa (L.) Flower

Nutritional and antinutritional contents of Parkia biglobosa flower were analysed using standard analytical methods. On dry weight basis, the flower had the following proximate compositions; ash (6.50 ± 1.00%), crude lipid (4.66 ± 0.29%), crude protein (6.77 ± 0.15%), available carbohydrate (78.9 ± 1.18%) and crude fibre (3.17 ± 0.29%). The calorific value was 384.7 kcal/100g. Mineral analysis indicates that the flower contain some essential minerals such as K, Na, Ca, Mg, and Zn, but was low in Cu, Mn, and Fe. The flower has low concentration of anti-nutritive factors: phytate (1.41±0.24mg %); oxalate (0.03±0.01mg %); hydrocyanic acid (0.17±0.01mg %) and nitrate (1.32±0.10mg %). The values are below the reference toxic standard levels. Therefore, P. biglobosa flower could supplement the microelements requirement, energy and to some extent protein

Determination of Nutritive Values of Garden Cress (Lepidium sativum L.) Leaves

The focus of this study was to investigate the nutritional values of Lepidium sativum leaves, a vegetable commonly consumed by the people of North-Western Nigeria. Sample of L. sativum leaves were collected from different farm lands at More town, Kware Local Government Area of Sokoto State. The leaves were dried then subjected to proximate, amino acids, minerals and antinutritional analyses. The results of proximate analysis indicate that the leaves had high crude protein (18.25%), crude fibre (9.31%) and ash (15.38%). The minera ls assay showed that the leaves are particularly high in potassium (1850.00 mg/100g), calcium (829.13 mg/100g), magnesium (160.60 mg/100g), sodium (141.13 mg/100g) and iron (63.47 mg/100g) with low level of phosphorus (4.10 mg/100g), manganese (5.74 mg/100g), copper (0.39 mg/100g) and chromium (0.36 mg/100g). The amino acid profile revealed that the leaf protein is generally low in lysine, sulphur containing amino acids (methionine and cystein), and threonine. Lysine was the most limiting amino acid in the leaves. In terms of antinutritional factors, the leaves had low concentrations of phytate (10.95 mg/100g), nitrate (0.05 mg/100g) and HCN (31.54mg/100g) with moderate amount of oxalate (337.50 mg/100g). Based on these nutrient contents, the leafy vegetable will have potential benefits as part of feeding programmes, as well as their promotion as part of composite die.Key words: Lepidium sativum, proximate analysis, amino acid, minerals, and antinutrients

Frequently Encountered Animal Diseases at Animal Hospital Birnin Kebbi, Kebbi State - Nigeria

Data from the clinical record of the Animal Hospital Birnin Kebbi was used to determine the frequency of occurrence of various diseases of animals from February 2009 to January 2010. A total of 794 cases were presented. 155 (19.5%) for routine check and vaccination, while the bulk 639 (80.5%)were presented as a result of disease conditions. Diseases diagnosed include; helminthoses 141(22%), followed by fowl pox 65(10.2%), lousiness 61(9.5%), traumatic injuries 46(7.2%), enteritis 32(5.0%), upper respiratory tract infection 29(4.5%), mite/mange 24(3.8%), septicemia22(3.4%), bloat 19(3.0%), and abscess 17(2.7%). Other moderately occurring, disorders included dystocia & post partum complications 14(2.2%) each, mal-directed horn/hooves 12(1.9%), tick infestation 10(1.6%), coccidiosis 9(1.4%), fracture 8(1.3%), hernia, PPR, pregnancy toxemia & castration 7(1.1%) each. Poisoning, infectious coryza, arthritis, rumen impaction & vaginal prolapse were 6(0.9%) each, pneumonia and mastitis 5(0.8%) each. The less occurring disorders included urinarytract infection, Gumboro disease, black leg, abortion, paraphimosis & dog bite 4(0.6%) each. Rhinitis & chronic respiratory diseases 3(0.5%) each, Foot and Mouth disease, New castle disease, cowdriosis, and hygroma numbering 2(0.3%) each. The least occurring disorders were Fowltyphoid, dislocation, trypanasomosis, pyometra, orf, stomatitis, grass tetany, canine distemper, atresia ani and rectal prolapse 1(0.2%) case each. Information generated can be useful to Government agencies involved in formulating policies and guidelines for prevention andcontrol of animal diseases

Molecular epidemiology of hcv among health care workers of khyber pakhtunkhwa

<p>Abstract</p> <p>Background</p> <p>Studies of the molecular epidemiology and risk factors for hepatitis C virus (HCV) in health care workers (HCWs) of Peshawar, Khyber Pakhtunkhwa region are scarce. Lack of awareness about the transmission of HCV and regular blood screening is contributing a great deal towards the spread of hepatitis C. This study is an attempt to investigate the prevalence of HCV and its possible association with both occupational and non-occupational risk factors among the HCWs of Peshawar.</p> <p>Results</p> <p>Blood samples of 824 HCWs, aged between 20-59 years were analysed for anti-HCV antibodies, HCV RNA and HCV genotypes by Immunochromatographic tests and PCR. All relevant information was obtained from the HCWs with the help of a questionnaire. The study revealed that 4.13% of the HCWs were positive for HCV antibodies, while HCV RNA was detected in 2.79% of the individuals. The most predominant HCV genotype was 3a and 2a.</p> <p>Conclusion</p> <p>A program for education about occupational risk factors and regular blood screening must be implemented in all healthcare setups of Khyber Pakhtunkhwa province in order to help reduce the burden of HCV infection.</p

Systems-Level Modeling of Cancer-Fibroblast Interaction

Cancer cells interact with surrounding stromal fibroblasts during tumorigenesis, but the complex molecular rules that govern these interactions remain poorly understood thus hindering the development of therapeutic strategies to target cancer stroma. We have taken a mathematical approach to begin defining these rules by performing the first large-scale quantitative analysis of fibroblast effects on cancer cell proliferation across more than four hundred heterotypic cell line pairings. Systems-level modeling of this complex dataset using singular value decomposition revealed that normal tissue fibroblasts variably express at least two functionally distinct activities, one which reflects transcriptional programs associated with activated mesenchymal cells, that act either coordinately or at cross-purposes to modulate cancer cell proliferation. These findings suggest that quantitative approaches may prove useful for identifying organizational principles that govern complex heterotypic cell-cell interactions in cancer and other contexts

Assessment of Clinical Outcomes Among Children and Adolescents Hospitalized With COVID-19 in 6 Sub-Saharan African Countries

Importance: Little is known about COVID-19 outcomes among children and adolescents in sub-Saharan Africa, where preexisting comorbidities are prevalent. / Objective: To assess the clinical outcomes and factors associated with outcomes among children and adolescents hospitalized with COVID-19 in 6 countries in sub-Saharan Africa. / Design, Setting, and Participants: This cohort study was a retrospective record review of data from 25 hospitals in the Democratic Republic of the Congo, Ghana, Kenya, Nigeria, South Africa, and Uganda from March 1 to December 31, 2020, and included 469 hospitalized patients aged 0 to 19 years with SARS-CoV-2 infection. / Exposures: Age, sex, preexisting comorbidities, and region of residence. / Main Outcomes and Measures: An ordinal primary outcome scale was used comprising 5 categories: (1) hospitalization without oxygen supplementation, (2) hospitalization with oxygen supplementation, (3) ICU admission, (4) invasive mechanical ventilation, and (5) death. The secondary outcome was length of hospital stay. / Results: Among 469 hospitalized children and adolescents, the median age was 5.9 years (IQR, 1.6-11.1 years); 245 patients (52.4%) were male, and 115 (24.5%) had comorbidities. A total of 39 patients (8.3%) were from central Africa, 172 (36.7%) from eastern Africa, 208 (44.3%) from southern Africa, and 50 (10.7%) from western Africa. Eighteen patients had suspected (n = 6) or confirmed (n = 12) multisystem inflammatory syndrome in children. Thirty-nine patients (8.3%) died, including 22 of 69 patients (31.9%) who required intensive care unit admission and 4 of 18 patients (22.2%) with suspected or confirmed multisystem inflammatory syndrome in children. Among 468 patients, 418 (89.3%) were discharged, and 16 (3.4%) remained hospitalized. The likelihood of outcomes with higher vs lower severity among children younger than 1 year expressed as adjusted odds ratio (aOR) was 4.89 (95% CI, 1.44-16.61) times higher than that of adolescents aged 15 to 19 years. The presence of hypertension (aOR, 5.91; 95% CI, 1.89-18.50), chronic lung disease (aOR, 2.97; 95% CI, 1.65-5.37), or a hematological disorder (aOR, 3.10; 95% CI, 1.04-9.24) was associated with severe outcomes. Age younger than 1 year (adjusted subdistribution hazard ratio [asHR], 0.48; 95% CI, 0.27-0.87), the presence of 1 comorbidity (asHR, 0.54; 95% CI, 0.40-0.72), and the presence of 2 or more comorbidities (asHR, 0.26; 95% CI, 0.18-0.38) were associated with reduced rates of hospital discharge. / Conclusions and Relevance: In this cohort study of children and adolescents hospitalized with COVID-19 in sub-Saharan Africa, high rates of morbidity and mortality were observed among infants and patients with noncommunicable disease comorbidities, suggesting that COVID-19 vaccination and therapeutic interventions are needed for young populations in this region

The Critical Need for Pooled Data on Coronavirus Disease 2019 in African Children: An AFREhealth Call for Action Through Multicountry Research Collaboration

Globally, there are prevailing knowledge gaps in the epidemiology, clinical manifestations, and outcomes of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection among children and adolescents; and these gaps are especially wide in African countries. The availability of robust age-disaggregated data is a critical first step in improving knowledge on disease burden and manifestations of coronavirus disease 2019 (COVID-19) among children. Furthermore, it is essential to improve understanding of SARS-CoV-2 interactions with comorbidities and coinfections such as human immunodeficiency virus (HIV), tuberculosis, malaria, sickle cell disease, and malnutrition, which are highly prevalent among children in sub-Saharan Africa. The African Forum for Research and Education in Health (AFREhealth) COVID-19 Research Collaboration on Children and Adolescents is conducting studies across Western, Central, Eastern, and Southern Africa to address existing knowledge gaps. This consortium is expected to generate key evidence to inform clinical practice and public health policy-making for COVID-19 while concurrently addressing other major diseases affecting children in African countries

Effect of SARS-CoV-2 Infection in Pregnancy on Maternal and Neonatal Outcomes in Africa: An AFREhealth Call for Evidence through Multicountry Research Collaboration

In the African context, there is a paucity of data on SARS-CoV-2 infection and associated COVID-19 in pregnancy. Given the endemicity of infections such as malaria, HIV, and tuberculosis (TB) in sub-Saharan Africa (SSA), it is important to evaluate coinfections with SARS-CoV-2 and their impact on maternal/infant outcomes. Robust research is critically needed to evaluate the effects of the added burden of COVID-19 in pregnancy, to help develop evidence-based policies toward improving maternal and infant outcomes. In this perspective, we briefly review current knowledge on the clinical features of COVID-19 in pregnancy; the risks of preterm birth and cesarean delivery secondary to comorbid severity; the effects of maternal SARS-CoV-2 infection on the fetus/neonate; and in utero mother-to-child SARS-CoV-2 transmission. We further highlight the need to conduct multicountry surveillance as well as retrospective and prospective cohort studies across SSA. This will enable assessments of SARS-CoV-2 burden among pregnant African women and improve the understanding of the spectrum of COVID-19 manifestations in this population, which may be living with or without HIV, TB, and/or other coinfections/comorbidities. In addition, multicountry studies will allow a better understanding of risk factors and outcomes to be compared across countries and subregions. Such an approach will encourage and strengthen much-needed intra-African, south-to-south multidisciplinary and interprofessional research collaborations. The African Forum for Research and Education in Health's COVID-19 Research Working Group has embarked upon such a collaboration across Western, Central, Eastern and Southern Africa

Skeletal Plasmacytoma: Progression of disease and impact of local treatment; an analysis of SEER database

<p>Abstract</p> <p>Background</p> <p>Previous reports suggest an as yet unidentifiable subset of patients with plasmacytoma will progress to myeloma. The current study sought to establish the risk of developing myeloma and determine the prognostic factors affecting the progression of disease.</p> <p>Methods</p> <p>Patients with plasmacytoma diagnosed between 1973 and 2005 were identified in the SEER database(1164 patients). Patient demographics and clinical characteristics, treatment(s), cause of death, and survival were extracted. Kaplan-Meier, log-rank, and Cox regression were used to analyze prognostic factors.</p> <p>Results</p> <p>The five year survival among patients initially diagnosed with plasmacytoma that later progressed to multiple myeloma and those initially diagnosed with multiple myeloma were almost identical (25% and 23%; respectively). Five year survival for patients with plasmacytoma that did not progress to multiple myeloma was significantly better (72%). Age > 60 years was the only factor that correlated with progression of disease (p = 0.027).</p> <p>Discussion</p> <p>Plasmacytoma consists of two cohorts of patients with different overall survival; those patients that do not progress to systemic disease and those that develop myeloma. Age > 60 years is associated with disease progression. Identifying patients with systemic disease early in the treatment will permit aggressive and novel treatment strategies to be implemented.</p